Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinhult

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Acta Oncologica (Stockholm, Sweden)|March 11, 2022
Diffusion tensor imaging in glioblastoma patients treated with volumetric modulated arc radiotherapy: a longitudinal studyAnna Rydelius, Björn Lampinen, Andreas Rundcrantz, et al.
Breast Cancer Research and Treatment|January 11, 2018
Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancerAnnelie Liljegren, Anna von Wachenfeldt, Edward Azavedo, et al.
Frontiers in Neuroscience|January 1, 2026
Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentationsEdin Zahirovic, Tim Salomonsson, Malte Knutsson, et al.
Tomography (Ann Arbor, Mich.)|April 21, 2018
Brain Tumor Characterization Using Multibiometric Evaluation of MRIFaris Durmo, Jimmy Lätt, Anna Rydelius, et al.
Journal of the International Neuropsychological Society : JINS|January 13, 2017
Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's DiseaseOve Almkvist, Elena Rodriguez-Vieitez, Steinunn Thordardottir, et al.
Cancers|October 27, 2022
Dialysis as a Novel Adjuvant Treatment for Malignant CancersSture Hobro, Anders Nilsson, Jan Sternby, et al.
Neuro-Oncology Advances|November 12, 2021
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastomaKatja Werlenius, Giuseppe Stragliotto, Michael Strandeus, et al.
Frontiers in Neuroscience|February 20, 2025
Differentiation between glioblastoma and solitary brain metastases using perfusion and amide proton transfer weighted MRIMalte Knutsson, Tim Salomonsson, Faris Durmo, et al.
Alzheimer'S Research & Therapy|May 12, 2018
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up studySteinunn Thordardottir, Elena Rodriguez-Vieitez, Ove Almkvist, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Trials|March 14, 2025
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trialErik Ehinger, Anna Darabi, Edward Visse, et al.
Acta Oncologica (Stockholm, Sweden)|March 11, 2022
Diffusion tensor imaging in glioblastoma patients treated with volumetric modulated arc radiotherapy: a longitudinal studyAnna Rydelius, Björn Lampinen, Andreas Rundcrantz, et al.
Breast Cancer Research and Treatment|January 11, 2018
Prospective blinded surveillance screening of Swedish women with increased hereditary risk of breast cancerAnnelie Liljegren, Anna von Wachenfeldt, Edward Azavedo, et al.
Frontiers in Neuroscience|January 1, 2026
Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentationsEdin Zahirovic, Tim Salomonsson, Malte Knutsson, et al.
Tomography (Ann Arbor, Mich.)|April 21, 2018
Brain Tumor Characterization Using Multibiometric Evaluation of MRIFaris Durmo, Jimmy Lätt, Anna Rydelius, et al.
Journal of the International Neuropsychological Society : JINS|January 13, 2017
Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's DiseaseOve Almkvist, Elena Rodriguez-Vieitez, Steinunn Thordardottir, et al.
Cancers|October 27, 2022
Dialysis as a Novel Adjuvant Treatment for Malignant CancersSture Hobro, Anders Nilsson, Jan Sternby, et al.
Neuro-Oncology Advances|November 12, 2021
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastomaKatja Werlenius, Giuseppe Stragliotto, Michael Strandeus, et al.
Frontiers in Neuroscience|February 20, 2025
Differentiation between glioblastoma and solitary brain metastases using perfusion and amide proton transfer weighted MRIMalte Knutsson, Tim Salomonsson, Faris Durmo, et al.
Alzheimer'S Research & Therapy|May 12, 2018
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up studySteinunn Thordardottir, Elena Rodriguez-Vieitez, Ove Almkvist, et al.
Pageof 6